{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:20:49Z","timestamp":1770564049403,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.brachy.2014.08.050","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T18:50:36Z","timestamp":1411757436000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["High-dose-rate brachytherapy in early oral cancer with close or positive margins"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-7399","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Petera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Sir\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ka\u0161aov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubo\u0161","family":"Tu\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Dole\u017ealov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2014.08.050_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archotol.1977.00780210068007","article-title":"Surgical treatment of squamous cell carcinoma of the oral tongue: Factors influencing survival","volume":"103","author":"Whitehurst","year":"1977","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.brachy.2014.08.050_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9610(71)90431-4","article-title":"Epidermoid carcinoma of the mobile tongue. Treatment by partial glosectomy alone","volume":"122","author":"Spiro","year":"1971","journal-title":"Am J Surg"},{"key":"10.1016\/j.brachy.2014.08.050_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: Current role of radiotherapy and chemotherapy","volume":"18","author":"Hung","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.brachy.2014.08.050_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0360-3016(90)90346-L","article-title":"Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue","volume":"19","author":"Mazeron","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.08.050_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0167-8140(91)90036-G","article-title":"Interstitial irradiation for carcinoma of the tongue and floor of mouth. Royal Marsden Hospital Experience 1970\u20131986","volume":"21","author":"Dearnaley","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/PL00002416","article-title":"Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx","volume":"177","author":"Grabenbauer","year":"2001","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2014.08.050_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00066-004-9196-x","article-title":"Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy","volume":"180","author":"Strnad","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2014.08.050_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/moe.2000.110087","article-title":"High-dose rate interstitial brachytherapy for stage I-II tongue cancer","volume":"90","author":"Umeda","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.brachy.2014.08.050_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0167-8140(95)01686-4","article-title":"Seven fractions of twice daily high-dose rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio","volume":"39","author":"Lau","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0360-3016(01)01561-9","article-title":"Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer","volume":"51","author":"Inoue","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.08.050_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1269\/jrr.44.37","article-title":"Brachytherapy for early oral tongue cancer: Low dose rate to high dose rate","volume":"44","author":"Yamazaki","year":"2003","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2014.08.050_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brachy.2009.10.003","article-title":"Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma","volume":"9","author":"Guinot","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2014.08.050_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pme.12.95","article-title":"Predicting factors for locoregional failure of high-dose-rate brachytherapy for early-stage oral cancer","volume":"9","author":"Petera","year":"2012","journal-title":"Personalized Med"},{"key":"10.1016\/j.brachy.2014.08.050_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0360-3016(01)01567-X","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head and neck carcinoma","volume":"50","author":"Nag","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.08.050_bib16","first-page":"1","article-title":"High does rate versus low dose rate brachytherapy for oral cancer \u2013 a meta-analysis of clinical trials","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brachy.2014.08.050_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5114\/jcb.2014.40726","article-title":"High dose rate interstitial brachytherapy for mobile tongue cancer: Preliminary results of a dose reduction trial","volume":"6","author":"Akiyama","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2014.08.050_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0360-3016(00)00538-1","article-title":"Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins","volume":"48","author":"Lapeyre","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.08.050_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0360-3016(99)00068-1","article-title":"Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: Factors influencing local control and soft tissue complications","volume":"44","author":"Fujita","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2014.08.050_bib20","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.joms.2011.02.012","article-title":"Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients","volume":"69","author":"El-Naaj","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.brachy.2014.08.050_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(03)00187-7","article-title":"Neck node metastasis after successful brachytherapy for early stage tongue carcinoma","volume":"68","author":"Nakagawa","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jjco\/hyt108","article-title":"Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer","volume":"43","author":"Matsumoto","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.rpor.2011.07.001","article-title":"Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer","volume":"16","author":"Tu\u010dek","year":"2011","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.brachy.2014.08.050_bib24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/cncr.27872","article-title":"Long-term regional control and survival in patients with \u201clow risk\u201d early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: The importance of tumor thickness","volume":"119","author":"Ganly","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2014.08.050_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/ijo_00000193","article-title":"VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker","volume":"34","author":"Sugiura","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.brachy.2014.08.050_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.joms.2005.11.105","article-title":"Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma","volume":"65","author":"Shang","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.brachy.2014.08.050_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.oraloncology.2011.04.013","article-title":"Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors","volume":"47","author":"Seki","year":"2011","journal-title":"Oral Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472114006424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472114006424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:08:13Z","timestamp":1761530893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472114006424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1538472114006424"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2014.08.050","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose-rate brachytherapy in early oral cancer with close or positive margins","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2014.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}